Cancer Biology Division Director & Associate Professor Dr. Julie Schwarz accepted a 2019 AACR Investigator Grant award to continue her work “Targeting CXCR2 to Improve Radiation Induced Anti-Tumor Immunity”
Aadel Chaudhuri, MD, PhD, Hong Chen, PhD, and Stephanie Markovina, MD, PhD have all been awarded multi-year NIH Grants, totaling over $3.7 million
Carl DeSelm, MD, PhD honored by NIH for innovative cancer research. He has been selected for inclusion in the High-Risk, High-Reward Research Program.
Aadel Chaudhuri, MD, PhD, and Carl DeSelm, MD, PhD, join the Radiation Oncology faculty as physician scientists.
Members of the Schwarz Lab received attention from the Washington University Source for their work combatting cervical cancer using drug therapies in combination with radiation.
Read the article: Cutting off cervical cancer’s fuel supply stymies tumors (Washington University in St. Louis School of Medicine News Release)
Dennis Hallahan, MD, and Qin Yang, MD, PhD, are awarded an R01 grant from the National Institutes of Health (NIH) for their proposal, “Develop a novel reprogramming approach for glioblastoma multiforme treatment”.
Nathan Wong (Xiaowei Wang Lab) defends his PhD thesis, “Indentification of Prognostic Cancer Biomarkers through the Application of RNA-Seq Technologies and Bioinformatics”.
Read more about Nathan Wong’s research in the December 2017 Trainee Corner.
Micah Luderer (Kareem Azab Lab) defends his PhD thesis, “Development of Novel Tumor-Targeted Compounds for Boron Neutron Capture Therapy”.
Read more about Micah Luderer’s research in the October 2017 Trainee Corner.
Jin Zhang, PhD, joins the Cancer Biology Division as an instructor with a focus on Bioinformatics.
Xiaowei Wang, PhD, is awarded an R01 grant from the National Institutes of Health (NIH) for his proposal, “MicroRNA biomarkers for oropharyngeal cancer”.
David Curiel, MD, PhD, is awarded an R01 grant from the National Institutes of Health (NIH) for his proposal, “NOVEL TARGETED ADENOVIRUS”.